4//SEC Filing
Spring Bank Pharmaceuticals, Inc. 4
Accession 0000899243-16-020579
CIK 0001566373operating
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:06 PM ET
Size
5.5 KB
Accession
0000899243-16-020579
Insider Transaction Report
Form 4
Afdhal Nezam H.
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2016-05-19+5,000→ 5,000 totalExercise: $10.97Exp: 2026-05-18→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]This option was granted on May 19, 2016, with 25% of the shares subject to the option vesting on January 1, 2017 and the remaining 75% of the shares subject to the option vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Spring Bank Pharmaceuticals, Inc.
CIK 0001566373
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001566373
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 4:06 PM ET
- Size
- 5.5 KB